a public good project by the
Synthesis
Company
of California

© 2026

John F. Carlquist | doi.page

0 works0 citations0 h-index

John F. Carlquist

Intermountain Healthcare(US)University of Utah(US)Intermountain Medical Center(US)

Publications by Year

Research Areas

Lipoproteins and Cardiovascular Health, Adipokines, Inflammation, and Metabolic Diseases, Atherosclerosis and Cardiovascular Diseases, Genetic Associations and Epidemiology, Pharmacogenetics and Drug Metabolism

Most-Cited Works

→ Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease(2011)1,937 cited
→ Multi-ethnic genome-wide association study for atrial fibrillation(2018)790 cited
→ Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation(2007)729 cited
→ Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population(2010)658 cited
→ Infection With Chlamydia pneumoniae Accelerates the Development of Atherosclerosis and Treatment With Azithromycin Prevents It in a Rabbit Model(1998)517 cited
→ A polymorphism within a conserved β₁-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure(2006)449 cited

→ Increased incidence of Chlamydiaspecies within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease(1996)421 cited

→ Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension(2006)398 cited

→ Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease and Serological Evidence for Chlamydia pneumoniae Infection(1999)337 cited

→ Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease(2000)236 cited